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Background: The aim of the present study was to evaluate the accuracy of two approaches using magnetic
resonance imaging (MRI) or combined ultrasonography (US) and anti-cyclic citrullinated peptide antibody (ACPA)
for diagnosis and classification of individuals with established rheumatoid arthritis (RA).
Methods: In 53 individuals from a population-based, cross-sectional study, historic fulfilment of the American College
of Rheumatology (ACR) 1987 criteria (“classification”) or RA diagnosed by a rheumatologist (“diagnosis”) were used as
standard references. The sensitivity, specificity and Area under Curve for Receiver Operating Characteristics curves
(ROC-area: (sensitivity + specificity)/2) were calculated for “current fulfilment of the ACR 1987 criteria” (list format),
“adapted ACR 1987 criteria” (list format, substituting IgM rheumatoid factor with ACPA and clinical joint swelling and
erosions on radiography with synovitis and erosions detected by US on a semi-quantitative scale), and RA MRI scoring
System (RAMRIS) scores on low-field MRI in the unilateral hand.
Results: For the ACR 1987 criteria the ROC-area was 75% (sensitivity/specificity = 50%/100%) (with “classification”
as standard reference) and 69% (44%/94%) (with “diagnosis” as standard reference), while for the adapted ACR
1987 criteria it was 86% (75%/97%) (classification) and 82% (72%/91%) (diagnosis). For RAMRIS synovitis score in
metacarpophalangeal (MCP) joints only (cut-off ≥5), the ROC-area (sensitivity/specificity) was 78% (62%/94%)
(classification) and 85% (69%/100%) (diagnosis), while for the total synovitis score of MCP joints plus wrist
(cut-off ≥10) it was 78% (62%/94%) (both classification and diagnosis).
Conclusions: Compared with the ACR 1987 criteria, low-field MRI alone or adapted criteria incorporating US and
ACPA increased the correct classification and diagnosis of RA.
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Rheumatoid arthritis (RA) is an autoimmune and often in-
capacitating inflammatory disease primarily affecting syn-
ovial joints. The treatment possibilities for patients with
RA have improved recently with the emergence of several
new disease-modifying antirheumatic drugs (DMARDs)
and a focus on early intervention and tight inflammatory
control [1]. Over time, a decrease in the numbers of swol-
len and tender joints, joint damage, disease activity, dis-
ability [2,3], and rates for most types of interventions of
orthopaedic surgery have also been observed [4-6].
As a consequence, however, it may be increasingly dif-
ficult to ascertain individuals with RA in cross-sectional
studies aiming to estimate disease occurrence or to ver-
ify RA in patients with established disease in clinical set-
tings. In this situation sensitive imaging techniques and
specific second generation anti-cyclic citrullinated pep-
tide antibody (ACPA) [7,8] may perhaps provide relevant
information.
In patients with arthritis, grey-scale (GS) ultrasonog-
raphy (US) is more sensitive than clinical examination
for detecting synovitis [9,10] and more sensitive than
conventional radiography for detecting bone erosions
[10,11]. Power Doppler (PD) has been introduced for
the assessment of synovitis and may provide additional
information [12,13].
There is growing evidence on the performance of low-
field, dedicated extremity magnetic resonance imaging
(MRI) units for detecting joint inflammation and dam-
age in RA. Low-field MRI is more sensitive than conven-
tional radiography for detecting bone erosions [14] and
with high-field MRI as standard reference the sensitivity
and specificity for detecting erosions and synovitis is
high [15]. In the detection of bone marrow oedema spe-
cificity is high but sensitivity only moderate [15,16].
In the field of US and MRI, different working groups
have developed standardized and reproducible assessment
techniques. For MRI, a semi-quantitative scoring system
(RA MRI scoring System, RAMRIS) and a core set of
basic MRI sequences have been published [17]. In US,
standards for modes of acquisition [18] and definitions of
joint pathologies have been proposed [19].
The aim of the present cross-sectional study was to com-
pare the accuracy of two new approaches using either low-
field MRI or combined US and ACPA with the American
College of Rheumatology (ACR) 1987 classification criteria
[20] in individuals with established RA. As gold standard
references we used the historical fulfilment of the ACR
1987 criteria and RA diagnosed by a rheumatologist.
Methods
Participants
In 2004, a population-based, cross-sectional study of
4,995 randomly selected individuals was conducted inthe southern part of Denmark with the aim of describing
the point and cumulative prevalence of RA. On the basis
of responses to a screening postal questionnaire, telephone
interviews and data from local and nationwide registers,
73 individuals from the sample attended a clinical examin-
ation. At the examination individuals who had self-
reported RA on the screening questionnaire by answering
“yes” to the item “Have you or have you ever had RA”
were invited to participate in the present study, which was
conducted in 2005. Details about the algorithm for invit-
ing individuals to the examination have previously been
reported [21].
Standard references
No true gold standard definition of RA exists, and the
most generally used in practice are fulfilment of the
ACR 1987 classification criteria. In the present study,
data from national and local registers, medical records
and questionnaires were collected at hospitals and from
general practitioners. All available materials were scruti-
nized to ascertain individuals in whom the historic fulfil-
ment of the ACR 1987 criteria could be documented
(classification) [21], and in the present study this was used
as the primary standard reference. To obtain an alternative
standard reference the disease status of the participants
was evaluated by a rheumatologist (AV) who retrospect-
ively was given access to the results of current investiga-
tions (except MRI, ACPA, and US) and documentation
from hospitals and general practitioners. The rheumatolo-
gist then indicated if the participant had RA or specified
an alternative diagnosis.
Investigations
During interviews, data on symptom duration, morning
stiffness, current medications, the Medical Outcomes
Study Short Form with 36 items (SF-36) [22] and
Health Assessment Questionnaire-Disability Index
(HAQ-DI) [23] were collected. Conventional radiog-
raphy of wrists, hands (posterior-anterior projection) and
feet (anterior-posterior projection) were evaluated for
Larsen-score [24] by an experienced radiologist, blinded to
all other information. According to this method a joint
with score ≥2 is erosive. Blood samples were examined
for ACPA (EliA IgG, Phadia ImmunoCap, enzyme-
linked immunosorbent assay (ELISA), cut-off ≥10 AU/l)
[7,8], IgM rheumatoid factor (RF) (ELISA, cut-off >8 IE/
ml), erythrocyte sedimentation rate (ESR, mm/hour),
and C-reactive protein (CRP, mg/l). In the individuals
with RA, disease activity scores were calculated using
28 joints and CRP (DAS28) [25].
Current 1987 ACR criteria
On the day MRI and US were performed, the participants
were examined for the presence of rheumatic nodules,
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blinded to all other information. Fulfilment of the list for-
mat of the ACR 1987 criteria on the day of the examin-
ation (“current ACR 1987 criteria”) was tested using the
following parameters: joint stiffness (≥60 minutes), rheum-
atic nodules, erosions on radiography (32 joints), RF, and
patterns of clinical joint swelling (38 joints).
US
The participants were examined by US using a General
Electric Logiq 9 BT03 ultrasound unit (General Electric,
Solingen, Germany) with a 14 Mhz linear active matrix
probe with fixed GS and PD settings. US was performed
by one of two rheumatologists (TL, LSA), blinded to all
other information. Prior to the present study, the exam-
iners performed an evaluation of inter-observer agree-
ment in a pilot study. Based on the semi-quantitative
scoring system described by Szkudlarek et al, GS syno-
vitis was graded 0-4, US bone erosions 0-3, and PD
synovitis 0-3 in the metacarpophalangeal (MCP), meta-
tarsophalangeal (MTP) and proximal interphalangeal
(PIP) joints [10,12,26]. In these joints, scores ≥2 were
considered to represent definite pathologies. In the
wrists, the same features were also evaluated, but only
graded 0-1 (0 = absent, 1 = present). Only joints with GS
synovitis score ≥1 were examined by PD. The joints were
examined in all accessible planes within 15-45 minutes.
Adapted 1987 ACR criteria
We defined the list format of the adapted ACR 1987 cri-
teria using the following parameters: joint stiffness (≥60
minutes), rheumatic nodules, RF substituted with ACPA
and clinical joint swelling and erosions on radiography
with US synovitis and US erosions (32 joints).
MRI
On the day the participants were investigated by US,
MRI of the non-dominant hand was performed using a
0.2 Tesla Artoscan MRI unit (Esaote Biomedica, Genoa,
Italy). The investigation focused on the wrist but, if in-
cluded in the field of view (FOV), MCP joints 2-5 were
also evaluated. Coronal T1-weighted (T1) short tau in-
version recovery (STIR) and T1 gradient echo (GE) three
dimensional (3D) sequences were performed before and
after intravenously injected gadodiamide (0.1 mmol/kg
body weight; Omniscan (Amersham Health, Norway)).
The following imaging parameters were used: STIR-
images: echo time (TE) 18 ms, repetition time (TR) 1100
ms, gap 0.0, slice thickness 3.0 mm, FOV 200 × 200 mm,
matrix 256 × 160. T1-GE-3D images: TE 12 ms, TR 30
ms, FOV 140 × 140 × 80 mm, matrix 192 × 160 × 80. The
images were evaluated according to RAMRIS [17] by one
experienced reader (BE) [27,28]. The RAMRIS scores
were assessed for synovitis (possible range for wrist andMCP joints 2-5: 0-21), bone oedema (0-69), bone erosion
(0-230), and for the present study a composite score was
calculated comprising all three joint pathologies.
Statistics
Comparisons between groups were made using χ2 for
binary and Mann-Whitney U tests for continuous vari-
ables (level of significance: 0.05; two-sided). The accur-
acy was evaluated using sensitivity, specificity and Area
under Curve (AUC) for Receiver Operating Characteris-
tics (ROC) curves. For specific cut-offs on a scale the
ROC-area was calculated as (sensitivity + specificity)/2.
The AUC for ROC curves and the ROC-area estimate the
correct classification of individuals by the index test. For
the RAMRIS scales areas under ROC curves were com-
pared using nonparametric statistics for correlated data
[29]. The inter-observer agreement was evaluated using
unweighted kappa statistics [30]. Statistics were calculated
using Stata, version 8.2. (StatCorp, College Station, Texas).
Ethics
Informed consent was acquired from all participants and
the study was approved by the local ethics committee
(Den Regionale Videnskabsetiske Komité for Ringkjøbing,
Ribe og Sønderjyllands Amt; reference no. 2426-02) and
the Danish Data Protection Agency (reference no. 2002-
41-2231).
Results
In the US study, 53 individuals were included; 20 histor-
ically fulfilled the ACR 1987 criteria (classification) and
18 were diagnosed as having RA (diagnosis). In three in-
dividuals MRI images were damaged during a flood and
could not be recovered. In 50 individuals the unilateral
wrist was investigated by MRI and in 31 the MCP joints
were also included (Figure 1). One individual with RA
(according to both standard references) had allergy and
was examined by MRI without gadodiamide.
In the group without RA, the individuals were diag-
nosed with inflammatory and non-inflammatory condi-
tions (Table 1).
The individuals who historically fulfilled the ACR 1987
criteria (classification) were significantly older, had higher
swollen and tender joint counts, ESR and CRP than those
who did not. They were also more often erosive on radiog-
raphy, ACPA and RF positive, currently treated with
DMARDs (monotherapy with methotrexate or sulfasala-
zine in 11, combination therapy in five individuals (includ-
ing anti-tumor necrosis factor alpha therapy in four)), had
higher HAQ-scores, GS synovitis and US erosive joint
counts, RAMRIS erosion and oedema scores in the wrist
and MCP joints, and synovitis scores in MCP joints. For
symptom duration, SF-36 physical component scores, the
fraction of females, the numbers of individuals with at
73 examined from survey
20 (did not want to participate
or did not self-report RA)
53 (73%) included
53 (73%) MRI







31 (43%), MCP joints 2-5
13 RA, classification
13 RA, diagnosis
31 (43%), wrist + MCP joints 2-5
13 RA, classification
13 RA, diagnosis
Figure 1 Numbers of participants in magnetic resonance imaging and ultrasonography analyses. Historic fulfilment of American College of
Rheumatology (ACR) 1987 criteria (classification) or diagnosis with rheumatoid arthritis (RA) by rheumatologist (diagnosis). MCP, metacarpophalangeal.
MRI, magnetic resonance imaging; US, ultrasonography.
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in the wrist the two groups were not significantly dif-
ferent (Table 2). Four (20%) of the individuals who ful-
filled the ACR 1987 criteria had DAS28 <2.6, 14 (70%)
had scores ≥3.2, and none had scores ≥5.1.
Index test
The sensitivity, specificity and ROC-area of the list format
of the ACR 1987 (“current ACR 1987 criteria”) were 50%,
100% and 75% (classification) and 44%, 94% and 69%
(diagnosis) (Table 3). For the list format of the adapted
ACR 1987 criteria with GS synovitis, US erosions and
ACPA, the sensitivity, specificity and ROC-area were 75%,
97% and 86% (classification) and 72%, 91% and 82% (diag-
nosis). If GS synovitis and US erosions were combinedTable 1 Diagnosis by rheumatologist in the 53 participants
Diagnosis Numbers (%)
Rheumatoid arthritis 18 (34)
Unspecified arthritis 1 (2)
Reactive arthritis 3 (6)
Psoriatic arthritis 1 (2)
Juvenile idiopathic arthritis 1 (2)
Arthralgia 16 (30)
Osteoarthritis 9 (17)
Low back pain 1 (2)
Gout 1 (2)
Haemochromatosis 2 (4)with RF (instead of ACPA), the specificity was slightly
lower. Combining GS synovitis, erosions on radiography
(instead of US erosions) and ACPA, the sensitivity de-
creased with no increase in specificity. Using PD synovitis
in the adapted ACR 1987 criteria, the specificity was 100%
but the sensitivity was lower than for the ACR 1987 cri-
teria (Table 3).
Looking at MRI in the MCP joints at cut-off ≥5 for
synovitis, the sensitivity, specificity and ROC-area were
62%, 94% and 78% (classification) and 69%, 100% and
85% (diagnosis). For the wrist and MCP joints combined
at cut-off ≥10 for synovitis, the sensitivity, specificity and
ROC-area were 62%, 94% and 78% (same values for both
classification and diagnosis) (Table 3). At no other cut-
off for the RAMRIS scales in the wrist, MCP, or MCP
and wrist joints combined was the ROC-area higher
than for the ACR 1987 criteria (Figure 2).
In the wrist, MCP and wrist and MCP joints com-
bined, the AUC for the composite scale was higher than
the AUC for the other joint pathologies detected by MRI
(Figure 2).
Pilot study
In the preceding pilot study, a total of 112 joints from four
RA patients (seven wrists, 35 MCP, 35 PIP, 35 MTP joints)
were evaluated by US. Overall, the kappa values for defin-
ite joint pathologies were 0.80 (95% confidence interval
(CI): 0.63-0.97) for GS synovitis, 0.75 (95% CI: 0.56-0.94)
for PD synovitis, and 0.84 (95% CI: 0.73-0.97) for US ero-
sions, corresponding to good or very good agreement.
Table 2 Characteristics in 53 participants according to historic fulfilment of the American College of Rheumatology
1987 criteria
Rheumatoid arthritis (n = 20) Not rheumatoid arthritis (n = 33) P-value
Female, n (%) 14 (70) 16 (49) .178
Age, years 72 (30-79) 59 (31-82) .008
Symptom duration, years§ 15 (2-32) 11 (1-53) .369
Swollen joint count (40 joints) 4.5 (0-10) 0 (0-6) .000
Tender joint count (40 joints) 10 (0-40) 3 (0-28) .006
Current treatment with DMARDs, n (%) 16 (80) 0 (0) .000
CRP, mg/l 5.5 (0-33) 3 (1-14) .050
ESR, mm/hour 17 (2-53) 5 (1-28) .000
Positive RF (>8 IE/ml), n (%) 13 (65) 1 (3) .000
Positive ACPA (≥10 AU/l), n (%) 12 (60) 0 (0) .000
Positive ACPA and RF, n (%) 11 (55) 0 (0) .000
SF-36, physical component score* 38 (21-60) 40 (16-57) .441
HAQ-DI* 0.5 (0-2.375) 0.25 (0-2.125) .049
DAS28 3.7 (1.8-5.0) NR NR
Radiography, erosive (32 joints, ≥1 joint with erosion), n (%) 12 (60) 2 (6) .000
Radiography, Larsen score 21.5 (0-80) 0 (0-13) .000
RAMRIS, erosion score (wrist)# 4 (0-125) 1 (0-6) .001
RAMRIS, erosion score (MCP-joints 2-5)† 1 (0-8) 0 (0-4) .009
RAMRIS, bone marrow oedema score (wrist)# 2 (0-18) 0 (0-9) .002
RAMRIS, bone marrow oedema score (MCP joints 2-5)† 0 (0-5) 0 (0-2) .025
RAMRIS, synovitis score (wrist)# 4 (1-9) 3 (1-6) .119
RAMRIS, synovitis score (MCP joints 2-5)† 6 (1-8) 3 (0-6) .017
GS synovitis joint count (30 joints, score≥2) 4.5 (0-19) 0 (0-6) .000
GS synovitis joint count (wrists) 1 (0-2) 0 (0-1) .001
PD joint count (30 joints; score≥2) 1 (0-14) 0 (0-2) .000
PD joint count (wrists) 0 (0-2) 0 (0-1) .001
US erosive joint count (30 joints, score≥2) 10.5 (0-23) 1 (0-10) .000
US erosive joint count (wrists) 0.5 (0-2) 0 (0-1) .000
US erosive (32 joints; ≥1 joint with erosion), n (%) 19 (95) 31 (94) .871
Values are median (range), unless otherwise stated. Mann-Whitney U test for continuous variables; χ2 test for proportions. §Rheumatoid arthritis, n = 19; not
rheumatoid arthritis, n = 32. *Not rheumatoid arthritis, n = 32. #Rheumatoid arthritis, n = 18, not rheumatoid arthritis n = 32. †Rheumatoid arthritis, n = 13; not
rheumatoid arthritis, n = 18. ACPA, anti-cyclic citrullinated peptide antibody; CRP, C-reactive protein; DAS28, disease activity score in 28 joints using CRP; DMARDs,
disease-modifying antirheumatic drugs; ESR, erythrocyte sedimentation rate; GS, grey-scale; HAQ-DI, Health Assessment Questionnaire-Disability Index; MCP,
metacarpophalangeal; NR, not relevant; PD, Power Doppler; RAMRIS, Rheumatoid Arthritis Magnetic Resonance Imaging scoring System; RF, IgM rheumatoid factor;
SF-36, Medical Outcomes Study Short Form (36 items); US, ultrasonography.
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The main finding of our study was that the correct clas-
sification of individuals with established RA was im-
proved with two new approaches using low-field MRI or
combined US and ACPA. Compared with the ACR 1987
criteria (“current ACR 1987 criteria”), the ROC-area in-
creased from 75% to 86% using the adapted ACR 1987
criteria (with US synovitis, US erosions, and ACPA) with
the historic fulfilment of the ACR 1987 criteria (classifi-
cation) as standard reference. Looking solely on MRI
synovitis in the MCP joints or wrist and MCP joints
combined, the ROC-area increased to 78% (i.e. withoutincorporating information from clinical, biochemical or
other imaging parameters). Although many of the indi-
viduals with RA were currently treated with DMARDs,
the sensitivity and specificity of the adapted ACR 1987
criteria was close to the accuracy of the ACR 1987 cri-
teria in a recent meta-analysis (sensitivity 79-80%, speci-
ficity 90-93%) [31].
In the US pilot study, the inter-observer agreement for
definite joint pathologies was high. Originally Szkudlarek
et al did not include the wrist in their scoring system
[10,12,26], but today we could have used a more detailed
scale for synovitis in the wrist [32]. Moreover, if all the
Table 3 Sensitivity, specificity and area under Receiver Operating Characteristics curve (ROC-area) of index test
Standard references
Historic fulfilment of ACR 1987 criteria Diagnosis by rheumatologist
Sensitivity Specificity ROC-area Sensitivity Specificity ROC-area
ACR 1987 criteria
50 (27-73) 100 (89-100) 75 (64-86) 44 (22-69) 94 (81-99) 69 (57-82)
Adapted ACR 1987 criteria
(GS synovitis, US erosions, ACPA)
75 (51-91) 97 (84-100) 86 (76-96) 72 (47-90) 91 (77-98) 82 (70-93)
Adapted ACR 1987 criteria
(GS synovitis, US erosions, RF)
75 (51-91) 94 (80-99) 84 (74-95) 72 (47-90) 87 (73-97) 80 (68-92)
Adapted ACR 1987 criteria
(GS synovitis, erosions on radiography, ACPA)
60 (36-81) 97 (84-100) 79 (67-91) 56 (31-79) 91 (77-98) 73 (61-86)
Adapted ACR 1987 criteria
(PD synovitis, US erosions, ACPA)
35 (15-59) 100 (89-100) 67 (57-78) 39 (17-64) 100 (90-100) 69 (58-81)
RAMRIS scale for synovitis
MCP joints 2-5 (cut-off ≥5) 62 (32-86) 94 (73-100) 78 (63-93) 69 (39-91) 100 (73-100) 85 (72-98)
Combined wrist and MCP joints 2-5 (cut-off ≥10) 62 (32-86) 94 (73-100) 78 (63-93) 62 (32-86) 94 (73-100) 78 (63-93)
Historic fulfilment of the American College of Rheumatology (ACR) 1987 criteria (classification) or diagnosis with rheumatoid arthritis by rheumatologist (diagnosis)
as standard reference, % (95% confidence interval). ACPA, anti-cyclic citrullinated peptide antibody; GS, grey-scale; MCP, metacarpophalangeal; PD, Power Doppler;
RAMRIS, Rheumatoid Arthritis Magnetic Resonance Imaging scoring System; RF, IgM rheumatoid factor; US, ultrasonography.
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ity of the adapted ACR 1987 criteria using PD synovitis
might have been higher.
The numbers of participants with at least one joint
with US erosions was equally high among those who
were classified as having RA and those who were not. In
previous studies erosions have often been detected in
healthy individuals [33] and individuals with arthritides
as diagnosed in our study [34-36].
To our knowledge, the accuracy of an approach including
US as a criterion for the classification of individuals with
RA in a cross-sectional design has not previously been sys-
tematically evaluated.
As a single test for RA, ACPA and RF have equal sen-
sitivity but ACPA has higher specificity [37]. In two pre-
vious, cross-sectional studies in hospital patients,
substituting rheumatic nodules and erosions on radiog-
raphy with ACPA, the sensitivity of the ACR 1987 criteria
increased with a decrease in specificity [38,39]. Adding
ACPA as a criterion to the ACR 1987 criteria, the sensitiv-
ity improved with little loss in specificity [39]. In our
study, most of the individuals with RA were both ACPA
and RF positive and the majority of those without RA
where ACPA and RF negative. This explains why the ac-
curacy of the adapted ACR 1987 criteria changed only
slightly when ACPA was used instead of RF.
Turning to MRI, with the diagnosis as standard refer-
ence the ROC-area (cut-off >5) on the RAMRIS scale forsynovitis in the MCP joints was 85%. Most of the indi-
viduals with RA had moderate disease activity and were
treated with methotrexate or sulfasalazine as monother-
apy and our results confirm that with MRI it is possible
to detect subclinical synovitis [40]. On the other hand,
using a low-field MRI unit and examining one individual
with RA without contrast agent we probably underesti-
mated the occurrence of bone marrow oedema [15,16]
and synovitis [41]. The non-dominant hand was exam-
ined by MRI but based on previous reports [42,43], we
do not think that this has biased our results.
The AUC for the ROC curves of the composite scale
comprising all three joint pathologies defined by RAM-
RIS was highest in every joint area, indicating that both
damage and inflammation contributed with relevant in-
formation for the correct classification of the individuals.
RA is a polyarticular disease and if more joint areas had
been investigated the AUC of the composite scale might
have been higher. However, the inclusion of more joint
areas will increase the acquisition time and using RAM-
RIS guidelines requires that contrast medium is adminis-
tered repeatedly and this would make low-field MRI less
patient-friendly. In a previous cross-sectional study of
consecutive outpatients diagnosed with RA and healthy
individuals, low-field MRI of the bilateral wrist and MCP
joints 2-5 was evaluated using a modified version of RAM-
RIS without contrast agent. The sensitivity and specificity
were 65% and 83% for bone oedema (the cut-off was not
Figure 2 Areas under Receiver Operating Characteristics curves for Rheumatoid Arthritis Magnetic Resonance Imaging scoring System.
Bone oedema, bone erosion, synovitis and composite scales in unilateral wrist and metacarpophalangeal (MCP) joints 2-5 with historic fulfilment
of American College of Rheumatology 1987 criteria (classification, c) or diagnosis with rheumatoid arthritis by rheumatologist (diagnosis, d) as
standard references (95% confidence interval).
Pedersen et al. BMC Musculoskeletal Disorders 2014, 15:268 Page 7 of 10
http://www.biomedcentral.com/1471-2474/15/268clearly stated), 70% and 80% for synovitis (score >2) and
55% and 90% for erosions (>5 erosions) [43].
Our study was conducted in 2005 with the ACR 1987 cri-
teria to test. Recently, new classification criteria for RA have
been introduced (2010 ACR/European League Against
Rheumatism (EULAR) criteria) for the early identification
of individuals with arthritis at high risk of developing ero-
sive or persistent disease [44]. The participants did not allhave at least one swollen joint at the clinical examination,
which is the eligibility criterion for testing with the 2010
ACR/EULAR criteria. Consequently, we did not perform
post hoc analyses with the new criteria. Neither did we use
previously described criteria for the ascertainment of indi-
viduals with RA in twin studies [45].
However, after the introduction of the new criteria for
RA it seems that a fraction may only fulfil the ACR 1987
Pedersen et al. BMC Musculoskeletal Disorders 2014, 15:268 Page 8 of 10
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often achieve drug free remission [47] and it is not clear if
the new criteria may be applied meaningfully in a retro-
spective or cumulative way [48]. It therefore still seems
relevant to estimate the incidence and prevalence of RA
using the 1987 ACR criteria, until more descriptive data
with the 2010 ACR/EULAR criteria have been published.
The main weakness of the present study is that the low
numbers of participants resulted in rather wide and over-
lapping confidence intervals for the point estimates of ac-
curacy. Nevertheless, the participants were recruited from
a random sample of the general population and we think
that the approaches described here may be used in future
epidemiological studies conducted with the aim of esti-
mating the prevalence of RA in a selected population.
In our opinion, the high fraction of individuals with
non-inflammatory conditions after the diagnostic workup
reflects the general methodological problem that in popu-
lation based studies aiming to describe the prevalence of
RA, it is difficult to identify individuals at high risk of hav-
ing RA [21]. Many of the participants in our study had ac-
tually been seen in ambulatory settings and our results
may also apply to a hospital outpatient population. How-
ever, since the accuracy of an index test may change with
the disease severity among the cases and the spectrum of
diseases among the non-cases [49], this assumption should
be tested in a consecutive series of outpatients.
Conclusions
In this cross-sectional study the correct classification of
individuals with established RA was improved over what
was seen for the ACR 1987 criteria by two new approaches
either using low-field MRI or a combination of US and
ACPA. Our results may apply to cross-sectional epidemio-
logical studies conducted with the aim of estimating the
prevalence of RA. Whether they also apply for patients in
ambulatory settings has to be confirmed.
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